MEDSCAPE - New Antibiotics in the Pipeline But Situation Still Dire, Oct 31, 2011

"October 22, 2011 (Boston, Massachusetts) — Although there has been progress in the clinical development of new antimicrobial agents against resistant Gram-negative bacteria, there are still none active against panresistant Gram-negative bacteria.
In its 10 ₓ '20 campaign, the Infectious Diseases Society of America (IDSA) has set a goal of developing 10 effective and safe systemic antimicrobial agents by 2020.
Helen Boucher, MD, associate professor of medicine in the division of geographic medicine and infectious diseases and director of the infectious diseases fellowship program at Tufts University School of Medicine in Boston, Massachusetts, described the campaign here at the IDSA 49th Annual Meeting."